{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:55:45Z","timestamp":1786982145806,"version":"build-2736575974"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11926-020-00966-9","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T05:58:16Z","timestamp":1613023096000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Into Clinical Practice: Diagnosis and Therapy of Retroperitoneal Fibrosis"],"prefix":"10.1007","volume":"23","author":[{"given":"Paride","family":"Fenaroli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Maritati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Vaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"key":"966_CR1","unstructured":"Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. Jan 21 2006;367(9506):241\u201351."},{"issue":"4","key":"966_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","volume":"88","author":"EF van Bommel","year":"2009","unstructured":"van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse AL. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore). Jul 2009;88(4):193\u2013201.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"966_CR3","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/rheumatology\/kev225","volume":"54","author":"A Palmisano","year":"2015","unstructured":"Palmisano A, Urban ML, Corradi D, Cobelli R, Alberici F, Maritati F, et al. Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis? Rheumatology (Oxford). Nov 2015;54(11):2004\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"966_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/sj.ki.5002427","volume":"72","author":"D Corradi","year":"2007","unstructured":"Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int. Sep 2007;72(6):742\u201353. https:\/\/doi.org\/10.1038\/sj.ki.5002427.","journal-title":"Kidney Int"},{"issue":"3","key":"966_CR5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.berh.2008.12.002","volume":"23","author":"A Palmisano","year":"2009","unstructured":"Palmisano A, Vaglio A. Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol. Jun 2009;23(3):339\u201353.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"966_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/BOR.0b013e328341137d","volume":"23","author":"A Vaglio","year":"2011","unstructured":"Vaglio A, Pipitone N, Salvarani C. Chronic periaortitis: a large-vessel vasculitis? Curr Opin Rheumatol. Jan 2011;23(1):1\u20136. https:\/\/doi.org\/10.1097\/BOR.0b013e328341137d.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"966_CR7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","volume":"92","author":"A Khosroshahi","year":"2013","unstructured":"Khosroshahi A, Carruthers MN, Stone JH, Shinagare S, Sainani N, Hasserjian RP, et al. Rethinking Ormond's disease: \u201cidiopathic\u201d retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore). Mar 2013;92(2):82\u201391.","journal-title":"Medicine (Baltimore)"},{"key":"966_CR8","doi-asserted-by":"crossref","unstructured":"Maritati F, Rocco R, Accorsi Buttini E, et al. Clinical and prognostic significance of serum IgG4 in chronic periaortitis. an analysis of 113 patients. Front Immunol. 2019;10:693.The largest RPF study on the prognostic role of serum IgG4.","DOI":"10.3389\/fimmu.2019.00693"},{"key":"966_CR9","unstructured":"Palmisano A, Maritati F, Vaglio A. Chronic Periaortitis: an Update. Curr Rheumatol Rep. Nov 5 2018;20(12):80."},{"key":"966_CR10","unstructured":"Goldoni M, Bonini S, Urban ML, et al. Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study. Ann Intern Med. Aug 5 2014;161(3):181\u20138."},{"key":"966_CR11","doi-asserted-by":"crossref","unstructured":"Greco P, Vaglio A, Corradi D, Cobelli R, Zompatori M, Buzio C. Tuberculosis as a trigger of retroperitoneal fibrosis. Clin Infect Dis. Oct 1 2005;41(7):e72\u20135.","DOI":"10.1086\/433189"},{"key":"966_CR12","unstructured":"Martorana D, Vaglio A, Greco P, et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum. Feb 15 2006;55(1):126\u201330."},{"key":"966_CR13","doi-asserted-by":"crossref","unstructured":"Martorana D, Marquez A, Carmona FD, et al. A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis. J Allergy Clin Immunol. Nov 2018;142(5):1662\u20131665. The first demonstration on a large cohort of the association between RPF and HLADRB1*03, a marker of autoimmunity.","DOI":"10.1016\/j.jaci.2018.06.045"},{"issue":"8","key":"966_CR14","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jcp.47.8.721","volume":"47","author":"AL Ramshaw","year":"1994","unstructured":"Ramshaw AL, Roskell DE, Parums DV. Cytokine gene expression in aortic adventitial inflammation associated with advanced atherosclerosis (chronic periaortitis). J Clin Pathol. Aug 1994;47(8):721\u20137.","journal-title":"J Clin Pathol"},{"issue":"6","key":"966_CR15","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/hep.21697","volume":"45","author":"Y Zen","year":"2007","unstructured":"Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology. Jun 2007;45(6):1538\u201346.","journal-title":"Hepatology."},{"key":"966_CR16","doi-asserted-by":"crossref","unstructured":"Urban ML, Maritati F, Palmisano A, et al. Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients. Ann Rheum Dis. 2020:433\u2013434. vol. 3.The largest study in patients with IgG4-unrelated RPF demonstrating rituximab efficacy in difficult-to-treat cases.","DOI":"10.1136\/annrheumdis-2019-216258"},{"issue":"42","key":"966_CR17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012631","volume":"97","author":"R Wallwork","year":"2018","unstructured":"Wallwork R, Wallace Z, Perugino C, Sharma A, Stone JH. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis. Medicine (Baltimore). Oct 2018;97(42):e12631.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"966_CR18","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/art.38032","volume":"65","author":"A Vaglio","year":"2013","unstructured":"Vaglio A, Catanoso MG, Spaggiari L, Magnani L, Pipitone N, Macchioni P, et al. Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum. Sep 2013;65(9):2469\u201375.","journal-title":"Arthritis Rheum"},{"key":"966_CR19","doi-asserted-by":"crossref","unstructured":"Nicastro M, Vescovini R, Maritati F, et al. Fibrocytes in chronic periaortitis: a novel mechanism linking inflammation and fibrosis. Arthritis Rheumatol. Nov 2019;71(11):1913\u20131922.The first demonstration of fibrocytes in RPF.","DOI":"10.1002\/art.41024"},{"issue":"12","key":"966_CR20","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/PAS.0b013e3181b72882","volume":"33","author":"Y Zen","year":"2009","unstructured":"Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol. Dec 2009;33(12):1833\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"966_CR21","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1681\/ASN.2015101110","volume":"27","author":"A Vaglio","year":"2016","unstructured":"Vaglio A, Maritati F. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol. Jul 2016;27(7):1880\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"966_CR22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4065\/mcp.2010.0663","volume":"86","author":"TA Kermani","year":"2011","unstructured":"Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc. Apr 2011;86(4):297\u2013303.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"966_CR23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MD.0b013e3181afc439","volume":"88","author":"PJ Scheel Jr","year":"2009","unstructured":"Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation. Medicine (Baltimore). Jul 2009;88(4):202\u20137.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"966_CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.rdc.2013.02.004","volume":"39","author":"PJ Scheel Jr","year":"2013","unstructured":"Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis. Rheum Dis Clin N Am. May 2013;39(2):365\u201381.","journal-title":"Rheum Dis Clin N Am"},{"issue":"2","key":"966_CR25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.urology.2009.02.052","volume":"74","author":"A Palmisano","year":"2009","unstructured":"Palmisano A, Cobelli R, Buzio C, Vaglio A. Peri-renal collateral circles. Urology. Aug 2009;74(2):292\u20133.","journal-title":"Urology."},{"issue":"1","key":"966_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MD.0b013e318207231e","volume":"90","author":"C Salvarani","year":"2011","unstructured":"Salvarani C, Calamia KT, Matteson EL, Hunder GG, Pipitone N, Miller DV, et al. Vasculitis of the gastrointestinal tract in chronic periaortitis. Medicine (Baltimore). Jan 2011;90(1):28\u201339. https:\/\/doi.org\/10.1097\/MD.0b013e318207231e.","journal-title":"Medicine (Baltimore)"},{"key":"966_CR27","unstructured":"Frech A, Gratl A, Fraedrich G, Glodny B, Klocker J. Periaortitis as a rare complication after endovascular aneurysm repair. Circulation. Apr 21 2015;131(16):1459\u201361."},{"issue":"7","key":"966_CR28","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1093\/ndt\/gfr779","volume":"27","author":"LG Pelkmans","year":"2012","unstructured":"Pelkmans LG, Aarnoudse AJ, Hendriksz TR, van Bommel EF. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant. Jul 2012;27(7):2819\u201325.","journal-title":"Nephrol Dial Transplant"},{"key":"966_CR29","unstructured":"Vaglio A, Versari A, Fraternali A, Ferrozzi F, Salvarani C, Buzio C. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis. Arthritis Rheum. Feb 15 2005;53(1):122\u20135."},{"key":"966_CR30","unstructured":"Magrey MN, Husni ME, Kushner I, Calabrese LH. Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis? Arthritis Rheum. May 15 2009;61(5):674\u20139."},{"issue":"6","key":"966_CR31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.10.046","volume":"71","author":"A Fernando","year":"2017","unstructured":"Fernando A, Pattison J, Horsfield C, D'Cruz D, Cook G, O'Brien T. [(18)F]-Fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study. Eur Urol. Jun 2017;71(6):926\u201333.","journal-title":"Eur Urol"},{"key":"966_CR32","doi-asserted-by":"crossref","unstructured":"Raffiotta F, da Silva Escoli R, Quaglini S, et al. Idiopathic retroperitoneal fibrosis: long-term risk and predictors of relapse. Am J Kidney Dis. Dec 2019;74(6):742\u2013750.A well-structured study on relapse predictors in RPF.","DOI":"10.1053\/j.ajkd.2019.04.020"},{"issue":"9","key":"966_CR33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s10157-019-01759-w","volume":"23","author":"D Moriconi","year":"2019","unstructured":"Moriconi D, Giannese D, Capecchi R, Cupisti A, Barsotti S, Morganti R, et al. Risk factors for relapse and long-term outcome of idiopathic retroperitoneal fibrosis. Clin Exp Nephrol. Sep 2019;23(9):1147\u201353.","journal-title":"Clin Exp Nephrol"},{"issue":"7","key":"966_CR34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.autrev.2006.03.011","volume":"5","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Greco P, Corradi D, Palmisano A, Martorana D, Ronda N, et al. Autoimmune aspects of chronic periaortitis. Autoimmun Rev. Aug 2006;5(7):458\u201364.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"966_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.autrev.2014.08.006","volume":"14","author":"G Ceresini","year":"2015","unstructured":"Ceresini G, Urban ML, Corradi D, Lauretani F, Marina M, Usberti E, et al. Association between idiopathic retroperitoneal fibrosis and autoimmune thyroiditis: a case-control study. Autoimmun Rev. Jan 2015;14(1):16\u201322.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"966_CR36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2214\/AJR.07.3629","volume":"191","author":"CG Cronin","year":"2008","unstructured":"Cronin CG, Lohan DG, Blake MA, Roche C, McCarthy P, Murphy JM. Retroperitoneal fibrosis: a review of clinical features and imaging findings. AJR Am J Roentgenol. Aug 2008;191(2):423\u201331.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"966_CR37","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1148\/rg.334125081","volume":"33","author":"V George","year":"2013","unstructured":"George V, Tammisetti VS, Surabhi VR, Shanbhogue AK. Chronic fibrosing conditions in abdominal imaging. Radiographics. Jul-Aug 2013;33(4):1053\u201380.","journal-title":"Radiographics."},{"issue":"1 Suppl 64","key":"966_CR38","first-page":"S72","volume":"29","author":"N Pipitone","year":"2011","unstructured":"Pipitone N, Versari A, Vaglio A, Salvarani C. Role of 18F-fluorodeoxyglucose positron emission tomography in the workup of retroperitoneal fibrosis. Clin Exp Rheumatol. Jan-Feb 2011;29(1 Suppl 64):S72\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"966_CR39","first-page":"294","volume":"29","author":"SE Akhan","year":"2008","unstructured":"Akhan SE, Dogan Y, Akhan S, Iyibozkurt AC, Topuz S, Yalcin O. Pelvic actinomycosis mimicking ovarian malignancy: three cases. Eur J Gynaecol Oncol. 2008;29(3):294\u20137.","journal-title":"Eur J Gynaecol Oncol"},{"issue":"21","key":"966_CR40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003625","volume":"95","author":"D Gianfreda","year":"2016","unstructured":"Gianfreda D, Musetti C, Nicastro M, Maritati F, Cobelli R, Corradi D, et al. Erdheim-Chester disease as a mimic of IgG4-related disease: a case report and a review of a single-center cohort. Medicine (Baltimore). May 2016;95(21):e3625.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"966_CR41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.revmed.2014.10.008","volume":"36","author":"ML Urban","year":"2015","unstructured":"Urban ML, Palmisano A, Nicastro M, Corradi D, Buzio C, Vaglio A. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. Rev Med Interne. Jan 2015;36(1):15\u201321.","journal-title":"Rev Med Interne"},{"key":"966_CR42","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. Feb 9 2012;366(6):539-."},{"issue":"3","key":"966_CR43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.2011.155382","volume":"71","author":"A Vaglio","year":"2012","unstructured":"Vaglio A, Strehl JD, Manger B, Maritati F, Alberici F, Beyer C, et al. IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis. Mar 2012;71(3):390\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"966_CR44","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/14397595.2014.931908","volume":"25","author":"BS Koo","year":"2015","unstructured":"Koo BS, Koh YW, Hong S, Kim YJ, Kim YG, Lee CK, et al. Clinicopathologic characteristics of IgG4-related retroperitoneal fibrosis among patients initially diagnosed as having idiopathic retroperitoneal fibrosis. Mod Rheumatol. Mar 2015;25(2):194\u20138.","journal-title":"Mod Rheumatol"},{"issue":"4","key":"966_CR45","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10067-017-3542-8","volume":"36","author":"LG Pelkmans","year":"2017","unstructured":"Pelkmans LG, Hendriksz TR, Westenend PJ, Vermeer HJ, van Bommel EFH. Elevated serum IgG4 levels in diagnosis and treatment response in patients with idiopathic retroperitoneal fibrosis. Clin Rheumatol. Apr 2017;36(4):903\u201312.","journal-title":"Clin Rheumatol"},{"issue":"7","key":"966_CR46","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/rheumatology\/keu462","volume":"54","author":"T Castelein","year":"2015","unstructured":"Castelein T, Coudyzer W, Blockmans D. IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis? Rheumatology (Oxford). Jul 2015;54(7):1250\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"966_CR47","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/1756-185X.13194","volume":"20","author":"IY Kim","year":"2017","unstructured":"Kim IY, Eun YH, Jeong H, Park TK, Kim H, Lee J, et al. Clinical characteristics and outcomes of 61 patients with chronic periaortitis including IgG4-related and non-IgG4-related cases. Int J Rheum Dis. Nov 2017;20(11):1751\u201362.","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"966_CR48","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0033-8389(22)00700-X","volume":"34","author":"JJ Kottra","year":"1996","unstructured":"Kottra JJ, Dunnick NR. Retroperitoneal fibrosis. Radiol Clin N Am. Nov 1996;34(6):1259\u201375.","journal-title":"Radiol Clin N Am"},{"issue":"2","key":"966_CR49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1148\/radiol.14131565","volume":"272","author":"B Bakir","year":"2014","unstructured":"Bakir B, Yilmaz F, Turkay R, \u00d6zel S, Bilgi\u00e7 B, Velioglu A, et al. Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study. Radiology. Aug 2014;272(2):438\u201345.","journal-title":"Radiology."},{"issue":"5","key":"966_CR50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e31826b1c1d","volume":"91","author":"T Mirault","year":"2012","unstructured":"Mirault T, Lambert M, Puech P, Argatu D, Renaud A, Duhamel A, et al. Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients. Medicine (Baltimore). Sep 2012;91(5):242\u201350.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"966_CR51","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejim.2010.02.008","volume":"21","author":"I Jansen","year":"2010","unstructured":"Jansen I, Hendriksz TR, Han SH, Huiskes AW, van Bommel EF. (18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Eur J Intern Med. Jun 2010;21(3):216\u201321.","journal-title":"Eur J Intern Med."},{"issue":"10","key":"966_CR52","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00259-012-2144-6","volume":"39","author":"G Moroni","year":"2012","unstructured":"Moroni G, Castellani M, Balzani A, Dore R, Bonelli N, Longhi S, et al. The value of (18)F-FDG PET\/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging. Oct 2012;39(10):1635\u201342.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"966_CR53","unstructured":"Salvarani C, Pipitone N, Versari A, et al. Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum. Apr 15 2005;53(2):298\u2013303."},{"issue":"4","key":"966_CR54","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.semarthrit.2017.07.011","volume":"47","author":"Y Wang","year":"2018","unstructured":"Wang Y, Guan Z, Gao D, Luo G, Li K, Zhao Y, et al. The value of (18)F-FDG PET\/CT in the distinction between retroperitoneal fibrosis and its malignant mimics. Semin Arthritis Rheum. Feb 2018;47(4):593\u2013600.","journal-title":"Semin Arthritis Rheum"},{"key":"966_CR55","doi-asserted-by":"crossref","unstructured":"Accorsi Buttini E, Maritati F, Vaglio A. [(18)F]-Fluorodeoxyglucose positron emission tomography and response to therapy in idiopathic retroperitoneal fibrosis. Eur Urol. Jan 2018;73(1):145-146. A study on a large cohort of RPF patients focusing on the role of PET in predicting response to therapy.","DOI":"10.1016\/j.eururo.2017.09.024"},{"issue":"2","key":"966_CR56","first-page":"231","volume":"23","author":"A Vaglio","year":"2005","unstructured":"Vaglio A, Greco P, Versari A, Filice A, Cobelli R, Manenti L, et al. Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent \u201cscar\u201d? A study using 18F-fluorodeoxyglucose positron emission tomography. Clin Exp Rheumatol. Mar-Apr 2005;23(2):231\u20134.","journal-title":"Clin Exp Rheumatol"},{"key":"966_CR57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2019.01.019","volume":"62","author":"G Morin","year":"2019","unstructured":"Morin G, Mageau A, Benali K, Bertinchamp R, Piekarski E, Raimbourg Q, et al. Persistent FDG\/PET CT uptake in idiopathic retroperitoneal fibrosis helps identifying patients at a higher risk for relapse. Eur J Intern Med. Apr 2019;62:67\u201371.","journal-title":"Eur J Intern Med"},{"key":"966_CR58","doi-asserted-by":"crossref","unstructured":"Koster MJ, Matteson EL, Warrington KJ. Large-vessel giant cell arteritis: diagnosis, monitoring and management. Rheumatology (Oxford). Feb 1 2018;57(suppl_2):ii32-ii42.","DOI":"10.1093\/rheumatology\/kex424"},{"key":"966_CR59","unstructured":"Abe H, Morikawa T, Araki A, et al. IgG4-related periureteral fibrosis presenting as a unilateral ureteral mass. Pathol Res Pract. Nov 15 2011;207(11):712\u20134."},{"issue":"4","key":"966_CR60","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.urology.2013.01.004","volume":"81","author":"C Ellimoottil","year":"2013","unstructured":"Ellimoottil C, Hart S, Mehta V, Quek ML. Localized perirenal retroperitoneal fibrosis. Urology. Apr 2013;81(4):e27\u20138.","journal-title":"Urology."},{"issue":"11","key":"966_CR61","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/rheumatology\/keh326","volume":"43","author":"RN Jois","year":"2004","unstructured":"Jois RN, Gaffney K, Marshall T, Scott DG. Chronic periaortitis. Rheumatology (Oxford). Nov 2004;43(11):1441\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"966_CR62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/iju.12234","volume":"21","author":"S Mertens","year":"2014","unstructured":"Mertens S, Zeegers AG, Wertheimer PA, Hendriksz TR, van Bommel EF. Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstruction. Int J Urol. Mar 2014;21(3):283\u20138.","journal-title":"Int J Urol"},{"issue":"5","key":"966_CR63","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.juro.2008.01.030","volume":"179","author":"AK Srinivasan","year":"2008","unstructured":"Srinivasan AK, Richstone L, Permpongkosol S, Kavoussi LR. Comparison of laparoscopic with open approach for ureterolysis in patients with retroperitoneal fibrosis. J Urol. 2008;179(5):1875\u20138.","journal-title":"J Urol"},{"key":"966_CR64","unstructured":"Vaglio A, Palmisano A, Alberici F, et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. Jul 23 2011;378(9788):338\u201346."},{"issue":"5","key":"966_CR65","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.ajkd.2007.02.268","volume":"49","author":"EF van Bommel","year":"2007","unstructured":"van Bommel EF, Siemes C, Hak LE, van der Veer SJ, Hendriksz TR. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis. May 2007;49(5):615\u201325.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"966_CR66","first-page":"231","volume":"60","author":"EF van Bommel","year":"2002","unstructured":"van Bommel EF. Retroperitoneal fibrosis. Neth J Med. Jul 2002;60(6):231\u201342.","journal-title":"Neth J Med"},{"key":"966_CR67","unstructured":"van Bommel EF, van Spengler J, van der Hoven B, Kramer P. Retroperitoneal fibrosis: report of 12 cases and a review of the literature."},{"issue":"2","key":"966_CR68","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-5347(05)64677-0","volume":"168","author":"AH Kardar","year":"2002","unstructured":"Kardar AH, Kattan S, Lindstedt E, Hanash K. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol. 2002;168(2):550\u20135.","journal-title":"J Urol"},{"issue":"4","key":"966_CR69","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archinte.1985.00360040191043","volume":"145","author":"E Cogan","year":"1985","unstructured":"Cogan E, Fastrez R. Azathioprine. An alternative treatment for recurrent idiopathic retroperitoneal fibrosis. Arch Intern Med. Apr 1985;145(4):753\u20135.","journal-title":"Arch Intern Med"},{"key":"966_CR70","unstructured":"Marcolongo R, Tavolini IM, Laveder F, et al. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med. Feb 1 2004;116(3):194\u20137."},{"issue":"3","key":"966_CR71","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/00365599409181272","volume":"28","author":"M Harreby","year":"1994","unstructured":"Harreby M, Bilde T, Helin P, Meyhoff HH, Vinterberg H, Nielsen VA. Retroperitoneal fibrosis treated with methylprednisolon pulse and disease-modifying antirheumatic drugs. Scand J Urol Nephrol. Sep 1994;28(3):237\u201342.","journal-title":"Scand J Urol Nephrol"},{"key":"966_CR72","doi-asserted-by":"crossref","unstructured":"Grotz W, von Zedtwitz I, Andre M, Schollmeyer P. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids. Lancet. 1998:1195. vol. 9135.","DOI":"10.1016\/S0140-6736(05)60533-8"},{"key":"966_CR73","doi-asserted-by":"crossref","unstructured":"Jois RN, Kerrigan N, Scott DG. Mycophenolate mofetil for maintenance of remission in idiopathic retroperitoneal fibrosis. Rheumatology (Oxford). 2007:717\u20138. vol. 4.","DOI":"10.1093\/rheumatology\/kel417"},{"issue":"4","key":"966_CR74","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.60.4.427","volume":"60","author":"A Marzano","year":"2001","unstructured":"Marzano A, Trapani A, Leone N, Actis GC, Rizzetto M. Treatment of idiopathic retroperitoneal fibrosis using cyclosporin. Ann Rheum Dis. Apr 2001;60(4):427\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"966_CR75","first-page":"358","volume":"33","author":"F Al-Harthy","year":"2006","unstructured":"Al-Harthy F, Esdaile J, Berean KW, Chalmers A. Multifocal idiopathic fibrosclerosis: treatment of 2 cases with cyclosporine. J Rheumatol. 2006;33(2):358\u201361.","journal-title":"J Rheumatol"},{"issue":"1","key":"966_CR76","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.juro.2007.03.057","volume":"178","author":"PJ Scheel Jr","year":"2007","unstructured":"Scheel PJ Jr, Piccini J, Rahman MH, Lawler L, Jarrett T. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis. J Urol. 2007;178(1):140\u20133 discussion 143-4.","journal-title":"J Urol"},{"key":"966_CR77","unstructured":"Scheel PJ, Jr., Feeley N, Sozio SM. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series. Ann Intern Med. Jan 4 2011;154(1):31\u20136."},{"issue":"4","key":"966_CR78","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02207688","volume":"14","author":"AS Scavalli","year":"1995","unstructured":"Scavalli AS, Spadaro A, Riccieri V, Ricciuti GP, Taccari E, Marini M, et al. Long-term follow-up of low-dose methotrexate therapy in one case of idiopathic retroperitoneal fibrosis. Clin Rheumatol. Jul 1995;14(4):481\u20134.","journal-title":"Clin Rheumatol"},{"key":"966_CR79","doi-asserted-by":"crossref","unstructured":"Alberici F, Palmisano A, Urban ML, et al. Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis. Ann Rheum Dis. 2013:1584\u20136. vol. 9.","DOI":"10.1136\/annrheumdis-2013-203267"},{"key":"966_CR80","doi-asserted-by":"crossref","unstructured":"Maritati F, Corradi D, Versari A, et al. Rituximab therapy for chronic periaortitis. Ann Rheum Dis. 2012:1262\u20134. vol. 7.","DOI":"10.1136\/annrheumdis-2011-201166"},{"key":"966_CR81","unstructured":"Benucci M, Damiani A, Li Gobbi F, et al. Jaccoud\u2019s arthropathy, an unusual manifestation of idiopathic retroperitoneal fibrosis: rapid improvement of symptoms after tocilizumab treatment. Reumatismo. Aug 3 2017;69(2):88\u201391."},{"issue":"3 Suppl 82","key":"966_CR82","first-page":"S79","volume":"32","author":"J Loricera","year":"2014","unstructured":"Loricera J, Blanco R, Castaneda S, et al. Tocilizumab in refractory aortitis: study on 16 patients and literature review. Clin Exp Rheumatol. May-Jun 2014;32(3 Suppl 82):S79\u201389.","journal-title":"Clin Exp Rheumatol"},{"key":"966_CR83","unstructured":"Perrotta FM, Fici M, Guerra G, Brunese L, Salvarani C, Lubrano E. Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report. Clin Exp Rheumatol. 2017:226\u2013227. vol. 1."},{"issue":"9","key":"966_CR84","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/ndt\/gfl228","volume":"21","author":"G Moroni","year":"2006","unstructured":"Moroni G, Gallelli B, Banfi G, Sandri S, Messa P, Ponticelli C. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and\/or medical approaches. Nephrol Dial Transplant. Sep 2006;21(9):2485\u201390.","journal-title":"Nephrol Dial Transplant"},{"key":"966_CR85","unstructured":"Guillevin L, Pagnoux C, Karras A, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. Nov 6 2014;371(19):1771\u201380."}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00966-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-020-00966-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00966-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T12:48:26Z","timestamp":1671194906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-020-00966-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-00966-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,10]]},"assertion":[{"value":"15 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"18"}}